Welcome to our dedicated page for EUDA Health Holdings SEC filings (Ticker: EUDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
EUDA’s blend of AI software, licensed clinics and cross-border telemedicine means its SEC disclosures read like both a tech prospectus and a medical-compliance manual. Sifting through dozens of forms to locate telehealth revenue, wellness-product margins or patient-data risk factors can overwhelm even seasoned analysts.
Stock Titan solves that problem. Our AI-powered analysis turns every EUDA SEC document—whether it’s a 20-F annual report, a 6-K interim update, or an 8-K material event filing—into clear takeaways you can act on. Need the latest EUDA quarterly earnings report 10-Q filing? We tag the KPIs and compare them to prior quarters. Tracking management moves? Receive instant alerts on EUDA insider trading Form 4 transactions plus a plain-English summary. Each filing lands here the moment EDGAR posts it, complete with side-by-side financial tables, keyword search and context from industry peers.
What can you uncover?
- Segment performance across Medical Services vs. Property Management—without wading through 300 pages.
- Revenue impact from EUDA’s Malaysian holistic-wellness acquisition, highlighted in the EUDA 8-K material events explained section.
- Executive pay details inside the EUDA proxy statement executive compensation filings.
- Real-time EUDA Form 4 insider transactions to gauge management’s confidence.
Whether you’re trying to understand EUDA SEC documents with AI, compare patient-volume trends, or review an EUDA annual report 10-K simplified, this page keeps every disclosure in one place—analyzed, summarized and ready for decision-making.
EUDA Health Holdings Ltd amended its annual report describing continued operating losses, a May 8, 2024 acquisition of CK Health Plus Sdn Bhd and significant non-cash impairment charges. The Company reported 37,153,049 ordinary shares outstanding as of December 31, 2024 and recorded a $14,755,560 impairment of intangible assets in 2024.
Management disclosed substantial doubt about the Company’s ability to continue as a going concern within one year, noting recurring losses since 2020, cash of approximately $0.2 million and a need to raise additional financing. The CK Health acquisition was settled with 8,571,428 newly issued shares valued at $15.0 million (at $1.75 per share), plus a contingent 1,000,000-share earnout tied to 2024–2025 net income milestones.
FAQ
What is the current stock price of EUDA Health Holdings (EUDA)?
What is the market cap of EUDA Health Holdings (EUDA)?
